BioNTech, once celebrated for its COVID-19 vaccines, is grappling with falling demand, restructuring and the departure of its ...

Pfizer’s first-quarter results gave investors a clearer view of how much work the drugmaker’s newer portfolio is doing as the ...

Yes, it's true Comirnaty is already available, but Georgia may not receive doses of the branded vaccine until mid-October. "During clinical trials and emergency use authorization, vaccines typically ...

The recent approval of the Pfizer-BioNTech coronavirus vaccine means more than just enticing some previously hesitant people to roll up their sleeves. The upgrade from an emergency use authorization ...

Add Yahoo as a preferred source to see more of our stories on Google. Pfizer and BioNTech's COVID-19 vaccine got full FDA approval on Monday. Its name, Comirnaty, is a mash-up of community, immunity, ...

Miami-based naming agency is the global leader in pharmaceutical name development MIAMI, Dec. 28, 2020 /CNW/ -- Brand Institute, the global leader in pharmaceutical and healthcare related name ...

Q1 2026 Management View Pfizer reported a Q1 it framed as operationally strong, with Chairman and CEO Albert Bourla saying, "We've had a strong start to the year. Our business continues to perform ...

• Spikevax and Comirnaty are brand names for the Moderna and Pfizer COVID-19 vaccines, respectively. The drug formulation is the same for the branded and non-branded vaccines. • The non-branded ...